Monica Banica
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Epigenetics and DNA Methylation, RNA Interference and Gene Delivery, Nanoplatforms for cancer theranostics, Immune Cell Function and Interaction
Most-Cited Works
- → Control of Effector CD8 + T Cell Function by the Transcription Factor Eomesodermin(2003)989 cited
- → Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs(2008)237 cited
- → Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302(2011)205 cited
- → STAT1 Plays a Critical Role in the Regulation of Antimicrobial Effector Mechanisms, but Not in the Development of Th1-Type Responses during Toxoplasmosis(2004)139 cited
- → Discovery of a Novel Class of Potent and Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists(2012)21 cited
- In vitro activity profile of the novel hypoxia-activated cytotoxic prodrug TH-302(2008)
- [The incidence of anti-HIV antibodies in hospitalized patients in a tuberculosis clinic].(1992)
- The in vivo antitumor activity of a humanized anti-CD26 monoclonal antibody(2007)
- → Supplementary Methods, Tables 1-5, Figures 1-9 from Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302(2023)